{
     "PMID": "1707738",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19910522",
     "LR": "20141120",
     "IS": "0006-8993 (Print) 0006-8993 (Linking)",
     "VI": "539",
     "IP": "1",
     "DP": "1991 Jan 18",
     "TI": "K+ efflux pathways and neurotransmitter release associated to hippocampal ischemia: effects of glucose and of K+ channel blockers.",
     "PG": "155-8",
     "AB": "Ischemia of hippocampal slices leads to 86Rb+ efflux and to amino acid neurotransmitter release. This 86Rb+ efflux which corresponds to the massive K+ efflux from neuronal cells observed in ischemic animals is inhibited by glucose (IC50 = 1.7 mM). Glucose also inhibits the ischemia induced liberation of GABA and aspartate. 86Rb+ efflux is insensitive to any type of known blockers for ATP-sensitive, Ca2(+)-sensitive and voltage-sensitive K+ channels.",
     "FAU": [
          "Schaeffer, P",
          "Lazdunski, M"
     ],
     "AU": [
          "Schaeffer P",
          "Lazdunski M"
     ],
     "AD": "Institut de Pharmacologie moleculaire et cellulaire, Valbonne, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Barium Compounds)",
          "0 (Chlorides)",
          "0 (Elapid Venoms)",
          "0 (Potassium Channels)",
          "0 (Scorpion Venoms)",
          "0 (Tetraethylammonium Compounds)",
          "0VK51DA1T2 (barium chloride)",
          "115422-61-2 (Charybdotoxin)",
          "24345-16-2 (Apamin)",
          "24GP945V5T (Barium)",
          "30KYC7MIAI (Aspartic Acid)",
          "56-12-2 (gamma-Aminobutyric Acid)",
          "66-40-0 (Tetraethylammonium)",
          "74811-93-1 (dendrotoxin)",
          "BH3B64OKL9 (4-Aminopyridine)",
          "IY9XDZ35W2 (Glucose)",
          "M4I0D6VV5M (Calcium Chloride)",
          "MLT4718TJW (Rubidium)",
          "RWP5GA015D (Potassium)",
          "SX6K58TVWC (Glyburide)",
          "X7WDT95N5C (Glipizide)"
     ],
     "SB": "IM",
     "MH": [
          "4-Aminopyridine/pharmacology",
          "Animals",
          "Apamin/pharmacology",
          "Aspartic Acid/metabolism",
          "Barium/pharmacology",
          "*Barium Compounds",
          "Brain Ischemia/*physiopathology",
          "Calcium Chloride/pharmacology",
          "Charybdotoxin",
          "*Chlorides",
          "Elapid Venoms/pharmacology",
          "Glipizide/pharmacology",
          "Glucose/*pharmacology",
          "Glyburide/pharmacology",
          "Hippocampus/*blood supply/physiology/physiopathology",
          "In Vitro Techniques",
          "Kinetics",
          "Potassium/*metabolism",
          "Potassium Channels/drug effects/*physiology",
          "Rats",
          "Rats, Inbred Strains",
          "Rubidium/*metabolism",
          "Scorpion Venoms/pharmacology",
          "Tetraethylammonium",
          "Tetraethylammonium Compounds/pharmacology",
          "gamma-Aminobutyric Acid/metabolism"
     ],
     "EDAT": "1991/01/18 00:00",
     "MHDA": "1991/01/18 00:01",
     "CRDT": [
          "1991/01/18 00:00"
     ],
     "PHST": [
          "1991/01/18 00:00 [pubmed]",
          "1991/01/18 00:01 [medline]",
          "1991/01/18 00:00 [entrez]"
     ],
     "AID": [
          "0006-8993(91)90699-V [pii]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 1991 Jan 18;539(1):155-8.",
     "term": "hippocampus"
}